Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency.

Advanced Search

Raseen Tariq, Darrell S Pardi, Pritish K Tosh, Randall C Walker, Raymund R Razonable, Sahil Khanna

Author Information

Raseen Tariq: Division of Gastroenterology and Hepatology.
Darrell S Pardi: Division of Gastroenterology and Hepatology.
Pritish K Tosh: Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.
Randall C Walker: Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.
Raymund R Razonable: Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.
Sahil Khanna: Division of Gastroenterology and Hepatology.

PMID: 29020210 DOI: 10.1093/cid/cix618

Broad-spectrum antibiotics for recurrent multidrug-resistant urinary tract infections (UTIs) disrupt the gut microbiome and promote antibiotic resistance. Fecal microbiota transplantation led to resolution of recurrent Clostridium difficile, significantly decreased recurrent UTI frequency, and improved antibiotic susceptibility profile of UTI-causing organisms.

C. difficile infection fecal transplant infection microbiome urinary tract infections

Aged

Aged, 80 and over

Anti-Bacterial Agents

Clostridioides difficile

Clostridium Infections

Fecal Microbiota Transplantation

Female

Humans

Male

Microbial Sensitivity Tests

Recurrence

Retrospective Studies

Urinary Tract Infections

Anti-Bacterial Agents

Journal Article

OpenLB
Open Library of Bioscience